GSTDTAP  > 资源环境科学
DOI10.1038/s41467-017-02348-9
NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPAR gamma
Luan, Peipei1,2; Jian, Weixia2; Xu, Xu1; Kou, Wenxin1; Yu, Qing1; Hu, Handan3; Li, Dali3; Wang, Wei4; Feinberg, Mark W.5; Zhuang, Jianhui1; Xu, Yawei1; Peng, Wenhui1
2019-06-28
发表期刊NATURE COMMUNICATIONS
ISSN2041-1723
出版年2019
卷号10
文章类型Article
语种英语
国家Peoples R China; USA
英文摘要

NLR Family CARD Domain Containing 5 (NLRC5), an important immune regulator in innate immunity, is involved in regulating inflammation and antigen presentation. However, the role of NLRC5 in vascular remodeling remains unknown. Here we report the role of NLRC5 on vascular remodeling and provide a better understanding of its underlying mechanism. Nlrc5 knockout (Nlrc5(-/-)) mice exhibit more severe intimal hyperplasia compared with wild-type mice after carotid ligation. Ex vivo data shows that NLRC5 deficiency leads to increased proliferation and migration of human aortic smooth muscle cells (HASMCs). NLRC5 binds to PPAR gamma and inhibits HASMC dedifferentiation. NACHT domain of NLRC5 is essential for the interaction with PPAR gamma and stimulation of PPAR gamma activity. Pioglitazone significantly rescues excessive intimal hyperplasia in Nlrc5(-/-) mice and attenuates the increased proliferation and dedifferentiation in NLRC5-deficient HASMCs. Our study demonstrates that NLRC5 regulates vascular remodeling by directly inhibiting SMC dysfunction via its interaction with PPAR gamma.


领域资源环境
收录类别SCI-E
WOS记录号WOS:000473132200046
WOS关键词MHC CLASS-I ; ACTIVATED-RECEPTOR-GAMMA ; NF-KAPPA-B ; NUCLEOTIDE-BINDING DOMAIN ; FAMILY-MEMBER NLRC5 ; SMOOTH-MUSCLE-CELL ; NOD-LIKE RECEPTORS ; ANTIGEN PRESENTATION ; KEY REGULATOR ; HOST-DEFENSE
WOS类目Multidisciplinary Sciences
WOS研究方向Science & Technology - Other Topics
URL查看原文
引用统计
文献类型期刊论文
条目标识符http://119.78.100.173/C666/handle/2XK7JSWQ/203595
专题资源环境科学
作者单位1.Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Cardiol, Shanghai 200072, Peoples R China;
2.Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Endocrinol, Shanghai 200092, Peoples R China;
3.East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci & Sch Life Sci, Shanghai 200241, Peoples R China;
4.Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10032 USA;
5.Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA 02115 USA
推荐引用方式
GB/T 7714
Luan, Peipei,Jian, Weixia,Xu, Xu,et al. NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPAR gamma[J]. NATURE COMMUNICATIONS,2019,10.
APA Luan, Peipei.,Jian, Weixia.,Xu, Xu.,Kou, Wenxin.,Yu, Qing.,...&Peng, Wenhui.(2019).NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPAR gamma.NATURE COMMUNICATIONS,10.
MLA Luan, Peipei,et al."NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPAR gamma".NATURE COMMUNICATIONS 10(2019).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Luan, Peipei]的文章
[Jian, Weixia]的文章
[Xu, Xu]的文章
百度学术
百度学术中相似的文章
[Luan, Peipei]的文章
[Jian, Weixia]的文章
[Xu, Xu]的文章
必应学术
必应学术中相似的文章
[Luan, Peipei]的文章
[Jian, Weixia]的文章
[Xu, Xu]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。